Wang Yahui, Yousefi Mojdeh, Fard Mohammad Reza Ghasemzadeh, Masihpour Nasrin, Ali Khiavi Payam, Yousefi Khadije, Hajizadeh Maryam, KarkonShayan Sepideh
School of Medical Technology, Beijing Institute of Technology, Beijing, 100081, China.
Department of Ophthalmology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Stem Cell Rev Rep. 2025 Apr;21(3):730-743. doi: 10.1007/s12015-025-10841-8. Epub 2025 Jan 9.
In the quest to transform vision care, researchers have been investigating novel methods to boost the efficacy of eye drops and enhance the survival of corneal limbal stem cells. Aimed at rejuvenating vision, these innovations seek to tackle a range of ocular conditions and restore sight to those in need. This article examines the most recent advancements in eye drops and corneal limbal stem cells, highlighting their potential to revolutionize ophthalmology. Findings from various studies indicate that the drive to rejuvenate vision has resulted in significant progress within the field of ophthalmology, especially regarding eye drops and corneal limbal stem cells. By improving the effectiveness of eye drops and increasing the survival rates of CLSCs, researchers are creating pathways for more sustainable and effective treatment options. These advancements offer great hope for patients experiencing various ocular issues, suggesting a future where vision restoration is attainable. As research continues to refine these strategies, we can look forward to an era marked by better visual outcomes and an enhanced quality of life for many individuals around the world.
在致力于变革视力保健的过程中，研究人员一直在研究新方法，以提高眼药水的功效并提高角膜缘干细胞的存活率。旨在恢复视力，这些创新旨在解决一系列眼部疾病，并为有需要的人恢复视力。本文探讨了眼药水和角膜缘干细胞的最新进展，突出了它们彻底改变眼科学的潜力。各项研究的结果表明，恢复视力的努力已在眼科学领域取得了重大进展，特别是在眼药水和角膜缘干细胞方面。通过提高眼药水的有效性和提高角膜缘干细胞的存活率，研究人员正在为更可持续和有效的治疗选择开辟道路。这些进展为患有各种眼部问题的患者带来了巨大希望，预示着未来视力恢复是可以实现的。随着研究不断完善这些策略，我们可以期待一个以更好的视觉效果和全球许多人生活质量提高为特征的时代。
